PRESENTATIONS FROM CONFERENCES

 Links to the videotaped presentations will be posted here when made available. 

OM Diagnosis, Genetics, Treatment, and Research: 

• How My Patients Made Me a Better Ocular Oncologist  (Dr. Bertil Damato; 43 minutes)

• Keynote Presentation: What's New in Uveal Melanoma in 2021  (Dr. Prithvi Mruthyunjaya; 43 minutes)

• Making Drug Development Work For Uncommon Cancers  (Dr. Anthony Tolcher; 44 minutes)

• Navigating a Diagnosis of Metastatic Uveal Melanoma  (Dr. Adil Daud and Dr. Justin Moser; 50 minutes)

• Treatment of Advanced Uveal Melanoma  (Dr. Jose Lutzky; 45 minutes)

• Uveal Melanoma Genetics Explained  (Jaime Jessen, genetic counselor, and Dr. Basil Williams; 52 minutes)

• What to Expect After Radiation Treatment for Uveal Melanoma: A Patient's Perspective  (Dr. Armin Afshar and Dr. Timothy Murray; 48 minutes)

• What's New in Uveal Melanoma — NCCN Guidelines' Prognostic Information and Standards of Care  (Dr. David Reichstein, Dr. Amy Schefler, and Dr. Andrew Stacey; 49 minutes) 

• Why Should I Join a Registry? About the INSIGHT Ocular Melanoma Patient Registry  (Dr. Armin Afshar and Dr. Bertil Damato; 44 minutes)

Mental Health and Self-Advocacy:

Links to videotaped conference presentations on these two topics can be found on EyeMelanoma.org's Patient Empowerment webpage. 

Low Vision:  

Links to videotaped conference presentations on low-vision tools and techniques can be found on EyeMelanoma.org's Vision-Related Support webpage. 

All videotaped presentations from this conference

All the meeting's ocular melanoma presentations can be viewed in the following two parts by anyone after free online registration. (Note: Select "not a healthcare professional" to eliminate pre-test process for continuing education credit.)

Part 1:

One-hour video — OM presentations begin at 11:50 mark in the following order:

• Potential Application of Liquid Biopsies for Uveal Melanoma  (Dr. Elin Gray; 6 minutes)

• Uveal Melanoma: Proteomic Biomarkers  (Dr. Vinit Mahajan; 5 minutes)

• Molecular-Guided Clinical Trial Design in Uveal Melanoma  (Dr. J. William Harbour; 7 minutes)

• Panel Discussion  (24 minutes)

View Part 1 as shown above

Part 2:

Two-hour video — In its first hour, OM presentations begin at 14:20 mark in the following order:

• Targeted Treatment of Uveal Melanoma with Viral-Like Drug Conjugates  (Dr. Ivana Kim; 6 minutes)

• Dose Reduction Strategies for Plaque Brachytherapy  (Dr. Miguel Materin; 5 minutes)

• Anti-VEGF vs. Intravitreal Steroids for Prevention of Vision Loss Due to Radiation Retinopathy  (Dr. Daniel Martin; 8 minutes)

• Panel Discussion  (26 minutes)

In its second hour, OM presentations begin at 1:07:10 mark in the following order:

• Drug Toxicities from Cancer Therapies  (Dr. Dan Gombos; 7 minutes)

• Machine Learning in Ocular Melanoma Detection  (Dr. Mandeep Sagoo; 8 minutes)

• AI-Based Histopathologic Tumor Analysis  (Dr. Zelia Correa; 6 minutes)

• Panel Discussion  (21 minutes)

• A Perspective on Unmet Needs in Uveal Melanoma  (Dr. Carol Shields; 10 minutes)

• Activating a Research Network to Tackle a Yet Uncured Disease: COOG2  (Dr. Thomas Aaberg, Jr.; 7 minutes)

• Panel Discussion  (25 minutes)

View Part 2 as shown above

Overview of Ocular Melanoma:

• Conjunctival Melanoma: Diagnosis to Treatment  (Dr. Dan Gombos; 25 minutes)

• OM in Childhood  (Dr. Mandeep Sagoo; 10 minutes)

• OM Patient Care: New Zealand and Australia Perspective  (Dr. Peter Hadden and Dr. Li-Anne Lim; 46 minutes)

• Primary OM 101  (Dr. Dan Gambos; 38 minutes)

• What is Uveal Melanoma? Whqt is Conjunctival Melanoma?  (Dr. Amit Arora and Dr. Mandeep Sagoo; 27 minutes)

OM Diagnosis, Genetics, Treatment, and Research:

• Adjuvant Therapy  (Dr. Marlana Orloff; 28 minutes)

• Clinical Trials: An International Overview  (Dr. Marcus Butler, Dr. Richard Carvajal, Dr. John Crown, and Dr. Anthony Joshua; 30 minutes)

• Collaborative Ocular Oncology Group's COOG2 Study  (Dr. Prithvi Mruthyunjaya; 15 minutes)

• Current Treatment Options: Liver-Directed Therapy, Immunotherapy, Targeted Therapy, and Looking to the Future, Plus COVID-19 Update  (Dr. Marlana Orloff and Dr. Sapna Patel; 50 minutes)

• Different Types of Radiotherapy for Uveal Melanoma in UK  (Dr. Rumana Hussain; 17 minutes)

• Genomic Landscape of Uveal Melanoma  (Dr. Nicholas Hayward; 48 minutes)

• Liver-Directed Interventional Radiology in US  (Dr. Ravi Murthy and Dr. Bruno Odisio; 22 minutes)

• Liver-Directed Interventional Radiology in UK  (Dr. Brian Stedman and Dr. Sachin Modi; 25 minutes)

• OM Treatment Progress Over the Last Few Decades  (Dr. Sapna Patel; 25 minutes)

• Side Effects of Plaque Brachytherapy Treatment of Ocular Melanoma  (Dr. Peter Hovland; 24 minutes)

• Precision (Personalized) Medicine in Choroidal Melanoma  (Dr. Tim Crook; 25 minutes)

• Prospective Ocular Melanoma Natural History Study ("OMNI" Registry)  (Dr. Joseph Sacco; 13 minutes)

• Radiation Oncology  (Dr. Clare Phillips; 28 minutes)

• Radiation Side Effects on the Retina, Radiation Retinopathy and Radiation Maculopathy  (Dr. Heinrich Heimann; 40 minutes)

• Translational Research: Genomic Landscape of UM, Immunotherapy for Metastatic UM, Liquid Biopsies  (Dr. Elin Gray, Dr. Nicholas Hayward, Dr. Jonas Nilsson; 48 minutes)

• Update on CURE OM's VISION Patient Registry  (Dr. Richard Carvajal, Chad Kimbler, Dr. Marlana Orloff, and George Ritacco; 60 minutes)

• Update on Unique Ocular Melanoma Populations (Huntersville in North Carolina and Auburn in Alabama)  (Dr. Marlana Orloff; 29 minutes)

Mental Health and Self-Advocacy:

Links to videotaped symposium presentations on these two topics can be found on EyeMelanoma.org's Patient Empowerment webpage.

All videotaped presentations from this symposium

OM Diagnosis, Genetics, Treatment, and Research: 

• Discoveries and Clinical Trials in Uveal Melanoma  (Dr. J. William Harbour; 42 minutes)

• Genetics of Uveal Melanoma  (Dr. Zelia Correa; 30 minutes)

• INSIGHT Global OM Patient Registry and OMNI OM Academic Registry  (Dr. Armin Afshar, Dr. Bertil Damato, Kristin Gygi, and Dr. Joseph Sacco; 53 minutes)

• Navigating Clinical Trials  (Dr. Kevin Kim; 42 minutes)

• Prosthetic Eyes  (Ocularist John Stolpe; 48 minutes)

• Radiation Maculopathy: Now a Treatable Condition  (Dr. Timothy Murray; 44 minutes)

• Standards of Care in OM  (Dr. Bertil Damato, Dr. Brian Marr, Dr. Prithvi Mruthyunjaya; 38 minutes)

Mental Health and Self-Advocacy:

Links to videotaped conference presentations on these two topics can be found on EyeMelanoma.org's Patient Empowerment webpage. 

Low Vision:

Links to videotaped conference presentations on low-vision tools and techniques can be found on EyeMelanoma.org's Vision-Related Support webpage.  

Other OM-Related Topics: 

• Melanoma Patient Network Europe Activities  (OM patient Andrew Evans and Dr. Bettina Ryll; 47 minutes)

All videotaped presentations from this conference